Evaluasi Nilai CTDIVOL Dan DLP Pada Pemeriksaan MSCT Abdomen Non Kontras Selama Periode Maret 2022 Sampai Juni 2022 Di Rumah Sakit TK II Pelamonia Makassar
DOI:
https://doi.org/10.4425/garuda.v4i2.276Keywords:
CTDIvol, DLP, MSCT AbdomenAbstract
Background, Supervision to ensure protection from radiation doses and safety for patients is very important so efforts are needed to optimize the application of radiation and medical exposure by applying the Diagnostic Reference Level (DRL). Monitoring and evaluation needs to be carried out at various health facilities that use radiation and then the evaluation results obtained are compared with the latest Indonesian Diagnostic Reference Level (IDRL) so that their implementation becomes effective. Non-contrast abdominal MSCT examination at TK II Pelamonia Hospital Makassar is an examination that is often done with a visit frequency of 30% compared to other examinations, there are vital organs in it and this examination has never been evaluated for radiation doses. The purpose, To find out the quartile 3 value of CTDIvol and DLP on the non-contrast abdominal MSCT examination for the period March 2022-June 2022 at the TK II Pelamonia Hospital Makassar is in accordance with the standard value of BAPETEN / IDRL 2021. Research methods, This study is a descriptive quantitative study with a survey approach which was carried out by collecting data from the MSCT Abdomen non-contrast examination in the period March 2022-June 2022. The value of DRL facilities was calculated using the quartile 3 formula in the SPSS statistical application automatically, then the resulting values were compared with the latest IDRL value. Results, Calculation of the 75th percentile values of CTDIvol and DLP in 137 study samples obtained 7,550 mGy for CTDIvol and 377,250 mGy*cm for DLP values. Conclusion: The quartile 3 values from CTDIvol and DLP received by patients on non-contrast abdominal MSCT examinations during the period March 2022-June 2022 at the TK II Pelamonia Hospital Makassar are in accordance with the recommendations of BAPETEN/IDRL 2021.
